Data in study show removal of tobacco from stores led to surge in purchase of nicotine patches.
CVS Health's decision a year ago to stop selling tobacco products was associated with a 1% drop in cigarette sales, according to a study by the company’s Health Research Institute.
CVS claims its decision resulted in an average reduction of 0.14 cigarette packs per smoker each month since the end of tobacco sales in its stores. In states where CVS has enough market share for the policy to make a difference, the average smoker bought 5 fewer packs of cigarettes.
The company paired its removal of tobacco products with a campaign to help smokers quit, which included counseling, a dedicated quit line, and nicotine replacement products. Compared with data from a control group of states with no CVS stores, the end of tobacco sales was associated with a 4% jump in purchases of nicotine patches, which the company interpreted as an attempt to quit. “This surge in nicotine patch purchases immediately following the tobacco sales removal decreased to preremoval levels over the subsequent months,” the authors wrote in the study.
To conduct the study, CVS Health analyzed cigarette pack and nicotine patch sales in 25 states where it has at least 15% market share, using data from 32 months before the end of tobacco sales and for 8 months after tobacco was removed. CVS determined the number of smokers in each state using data from the Behavioral Risk Factor Surveillance Survey. It also took into account seasonal patterns of attempts to quit, such as the increase that occurs each year on New Year’s Day.
The analysis was published September 4, 2015, almost a year to the day that tobacco sales ended on September 3, 2014. It examined the public health effects of the decision to pull all tobacco products from its retail stores as CVS Health positioned itself more broadly as a healthcare delivery provider.
It’s a strategy that appears to be paying off. In August the company reported rising earnings despite the loss of revenue from tobacco purchases and other items that smokers may buy while in the retail stores. This was offset by earnings from CVS Health’s pharmacy benefits management division.
“This evidence indicates that CVS Health’s decision to stop selling tobacco and to implement a robust smoking cessation program had a significant, nationwide impact on the public’s health,” wrote the authors, Jennifer M. Polinski ScD, MPH, Benjamin Howell, PhD, MPP, Chief Medical Officer Troyen A. Brennan, MD, JD, MPH, and Chief Scientific Officer William H. Shrank, MD, MSHS.
According to the American Lung Association, cigarette smoking is the leading cause of preventable death and disease in the world. Smoking-related illnesses kill more than 393,000 Americans each year. Smoking is the leading cause of lung cancer, which claims more lives than any other form of cancer.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More